These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32243785)

  • 1. Embracing the Landscape of Therapeutics.
    Cell Editorial Team
    Cell; 2020 Apr; 181(1):1-3. PubMed ID: 32243785
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-drug similarity measure and its applications.
    Huang L; Luo H; Li S; Wu FX; Wang J
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33152756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
    Kwon OS; Kim W; Cha HJ; Lee H
    Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes on the Horizon for Drug Repurposing, Rescue, and Repositioning at ASSAY.
    Melancon BJ; Mucke HAM
    Assay Drug Dev Technol; 2018; 16(4):193. PubMed ID: 29870272
    [No Abstract]   [Full Text] [Related]  

  • 5. The Drug Repurposing Hub: a next-generation drug library and information resource.
    Corsello SM; Bittker JA; Liu Z; Gould J; McCarren P; Hirschman JE; Johnston SE; Vrcic A; Wong B; Khan M; Asiedu J; Narayan R; Mader CC; Subramanian A; Golub TR
    Nat Med; 2017 Apr; 23(4):405-408. PubMed ID: 28388612
    [No Abstract]   [Full Text] [Related]  

  • 6. Relating anatomical therapeutic indications by the ensemble similarity of drug sets.
    Wu L; Ai N; Liu Y; Wang Y; Fan X
    J Chem Inf Model; 2013 Aug; 53(8):2154-60. PubMed ID: 23889502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the public landscape of clinical-stage pharmaceuticals through freely available online databases.
    Griesenauer RH; Schillebeeckx C; Kinch MS
    Drug Discov Today; 2019 Apr; 24(4):1010-1016. PubMed ID: 30690196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Overview of Drug Repurposing in Drug Discovery and Development.
    Olgen S
    Curr Med Chem; 2019; 26(28):5338-5339. PubMed ID: 31721690
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: computational methods for drug repurposing.
    Sanseau P; Koehler J
    Brief Bioinform; 2011 Jul; 12(4):301-2. PubMed ID: 21768130
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug repurposing a reality: from computers to the clinic.
    Issa NT; Kruger J; Byers SW; Dakshanamurthy S
    Expert Rev Clin Pharmacol; 2013 Mar; 6(2):95-7. PubMed ID: 23473587
    [No Abstract]   [Full Text] [Related]  

  • 11. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
    Yang CC; Zhao M
    Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
    Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
    Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early repositioning through compound set enrichment analysis: a knowledge-recycling strategy.
    Temesi G; Bolgár B; Arany A; Szalai C; Antal P; Mátyus P
    Future Med Chem; 2014 Apr; 6(5):563-75. PubMed ID: 24649958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the associations between drug side-effects and therapeutic indications.
    Wang F; Zhang P; Cao N; Hu J; Sorrentino R
    J Biomed Inform; 2014 Oct; 51():15-23. PubMed ID: 24727480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational application of drug promiscuity in medicinal chemistry.
    Mei Y; Yang B
    Future Med Chem; 2018 Aug; 10(15):1835-1851. PubMed ID: 30019924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opportunities of mining historical and collective data in drug discovery.
    Wassermann AM; Lounkine E; Davies JW; Glick M; Camargo LM
    Drug Discov Today; 2015 Apr; 20(4):422-34. PubMed ID: 25463034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design.
    Pihan E; Colliandre L; Guichou JF; Douguet D
    Bioinformatics; 2012 Jun; 28(11):1540-1. PubMed ID: 22539672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Repositioning and Target Finding Based on Clinical Evidence.
    Kaneko S; Nagashima T
    Biol Pharm Bull; 2020; 43(3):362-365. PubMed ID: 32115497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.
    Moosavinasab S; Patterson J; Strouse R; Rastegar-Mojarad M; Regan K; Payne PR; Huang Y; Lin SM
    Database (Oxford); 2016; 2016():. PubMed ID: 27189611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.